One of many troubling complications of infection with the SARS-CoV-2 coronavirus is its ability to trigger the formation of multiple blood clots, said Francis S. Collins, M.D., Ph.D.
It raises the question of whether and when more aggressive blood-thinning treatments might improve outcomes for people hospitalized for COVID-19, continued Dr. Collins’s blog published on February 2, 2021.
The answer to this question is desperately needed to help guide clinical practice.
Can Blood Thinners Keep Certain COVID-19 Patients Out of the ICU?
A Triumph for Injectable PrEP
A presentation on the HPTN 084 study delivered on January 27, 2021, confirmed the results announced when the trial was stopped early in November 2020 but added new details.
This presentation focused on women randomly allocated to receive injectable PrEP (every eight weeks) or oral PrEP (every day).
The study used a 'double-dummy' design, meaning that half the participants got active injectable cabotegravir and inactive placebo pills; the other half got inactive placebo injections and active tenofovir/emtricitabine pills.
>60 Percent Receiving COVID-19 Vaccine in U.S. Are Non-Hispanic Whites
Of those having received their first dose by Jan. 14, 2021, 63.0 percent were women, 55.0 percent were aged 50 years and older
Psychological Distress High Among Students During COVID-19
10.5 percent of students self-reported psychological distress; increased odds seem for those in high school, those who exercise less
Lack of Staff, PPE Hinder Nursing Homes’ Fight Against COVID-19
Although worker turnover in the nursing home industry has always been high, the pandemic has worsened the problem
Moderna Wants to Increase Number of Doses in COVID-19 Vaccine Vials
However, there are potential downsides to putting more vaccine in each vial